Grand Rapids May Be Second Michigan City to Decriminalize Natural Psychedelics by Year’s End
City Commissioner Kurt Reppart believes there is enough support to pass a resolution as early as fall.
Psychedelic Spotlight News
How the Heroic Hearts Project Is Spearheading Psilocybin Research to Treat Veterans for TBI
Dr. Grace Blest-Hopley tells Psychedelic Spotlight that the compound has anti-inflammatory effects on the brain, and explains how her team will investigate further through psilocybin retreats for veterans.
Matthew McConaughey Climbed in a Cage with a Mountain Lion? 5 Wildest Celebrity Trips on Psychedelics
From Carrie Fisher’s shirtless surprise for Japanese tourists to Gary Busey getting dosed by a co-star on set, these crazy trips are almost too wild to believe.
Psychedelic Business Spotlight: July 30, 2021
This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.
MindMed Launches DMT Clinical Trial (Joe Rogan Must Be Excited for MNMD)
MindMed Launches DMT Clinical Trial! Joe Rogan must be excited!
In this episode, we’ll discuss MindMed ‘s (NASDAQ: MNMD), ( NEO: MMED) announcement and why I’m personally excited about it.
As many of you know, of all the classic psychedelics, in many respects DMT, or dimethyltryptamine, is the most mysterious. When it is consumed, experiencers report being blasted off into an entirely new dimension of being or plane of existence, where you interact with autonomous, intelligent and wise beings. Those who have experienced this often claim that they return to our world with a sense of having learned important lessons, that are either too hard to put into words.
Now, we have no idea what is happening in a person’s brain while they are on DMT.
Is the experience completely physiological, for example has the DMT essentially initiated some sort of dream-like state while you are still conscious? Or is it more mystical than that?
Either way, the simplistic wisdom gained from “the spirit molecule”, as it is often called, has reportedly helped countless people beat their addictions, depression, anxiety and more.
Many people liken it to essentially “resetting your brain”.
Unfortunately, despite so much anecdotal evidence and entire sub cultures verging on the edge of religions dedicated to the substance, surprisingly little hard science has been done on the drug.
This is the reason behind my excitement today! MindMed announced initiation of phase 1 clinical trial of intravenous DMT.
Links:
MINDMED ANNOUNCES INITIATION OF PHASE 1 CLINICAL TRIAL OF INTRAVENOUS DMT:
https://thepsychedelicinvestor.com/2021/07/28/mindmed-announces-initiation-of-phase-1-clinical-trial-of-intravenous-dmt/
MindMed’s DMT Clinical Trial Specifications:
https://clinicaltrials.gov/ct2/show/NCT04353024?term=DMT&draw=2&rank=2
Previous DMT Studies:
https://www.nature.com/articles/s41598-020-61169-x
https://maps.org/research-archive/ayahuasca/Thomas_et_al_CDAR.pdf
Enjoy the episode!
Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com
Music from:
www.bensound.com
Video editing: @themyaholy
Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#MindMed #DMT #MNMD
Oregon Psilocybin Advisory Board Finds the Psychedelic Reduces Depression and Anxiety
The subcommittee’s review is the largest of its kind to be conducted in the state, which legalized psilocybin for therapeutic and medicinal purposes last November.
TheraPsil’s Fight to Secure Therapeutic Psilocybin Access for All Canadians
CEO Spencer Hawkswell calls current exemptions for terminally ill under Section 56 of Canada’s Controlled Drugs and Substances Act a “half-assed solution,” and is lobbying for more.
Pennsylvania Lawmakers to Propose Legalizing Psilocybin for Therapeutic Use
Republican Tracy Pennycuick and Democrat Jennifer O’Mara are the latest politicians to take notice of the proven therapeutic use of psilocybin.
Interview With Spencer Hawkswell
In this episode of the Psychedelic Spotlight podcast, we speak with Spencer Hawkswell, CEO of TheraPsil.
Ayahuasca May Help Curb Drug and Alcohol Addiction
New study compiles the experiences of 8,629 ayahuasca users from 40 different countries, and results are very promising for the future of psychedelic-assisted therapy.
End of content
End of content